Akebia Therapeutics , Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced plans to release its financial results for the first quarter ended March 31, 2020 , on Tuesday, May 5, 2020 before the opening of
April 28, 2020
· 1 min read